Ann: Teva Launches Generic Version of Axiron in United States, page-6

These results are far worse than even I expected. What we are looking at here is the end of the story for Axiron.

Interesting that we see management have decided to ramp up R&D even more (more generics) just at the very moment when the money to pay for it has dried up. Every decision that these bumbling fools have made in the last 3 years has proven to be the exact opposite of what is required..

For those of you that are old enough to remember the TV comedy Seinfeld, you may remember a character called George Costanza, a man who failed at everything he turned his hand to. So in one episode, George decided to do the exact opposite of what he would normally do - of course he started succeeding big time (except when he had trouble working out what the opposite might be). I think this episode should be compulsory viewing at ACR.

My next prediction is that it will not be long before they decide that a CR is needed to fund their bonuses....I am sorry...I meant to say fund more R&D. Sometimes with me the truth just pops out by accident...